164 related articles for article (PubMed ID: 34345559)
1. Encephalitis Associated With Hemophagocytic Lymphohistiocytosis Secondary to Immune Checkpoint Inhibitors: An Unfamiliar Spin-Off.
Ghous G; Shoukat HMH; Tarar ZI; Zafar MU; McGreevy JW
Cureus; 2021 Jun; 13(6):e16079. PubMed ID: 34345559
[TBL] [Abstract][Full Text] [Related]
2. Hemophagocytic lymphohistiocytosis with immunotherapy: brief review and case report.
Sadaat M; Jang S
J Immunother Cancer; 2018 Jun; 6(1):49. PubMed ID: 29871698
[TBL] [Abstract][Full Text] [Related]
3. Severe hemophagocytic lymphohistiocytosis in a melanoma patient treated with ipilimumab + nivolumab.
Hantel A; Gabster B; Cheng JX; Golomb H; Gajewski TF
J Immunother Cancer; 2018 Jul; 6(1):73. PubMed ID: 30012206
[TBL] [Abstract][Full Text] [Related]
4. Hemophagocytic lymphohistiocytosis with advanced malignant melanoma accompanied by ipilimumab and nivolumab: A case report and literature review.
Mizuta H; Nakano E; Takahashi A; Koyama T; Namikawa K; Yamazaki N
Dermatol Ther; 2020 May; 33(3):e13321. PubMed ID: 32191382
[TBL] [Abstract][Full Text] [Related]
5. Hemophagocytic Lymphohistiocytosis Secondary to Immune Checkpoint Inhibitor Therapy.
Rajapakse P; Andanamala H
World J Oncol; 2022 Apr; 13(2):49-52. PubMed ID: 35571340
[TBL] [Abstract][Full Text] [Related]
6. Effective Treatment of a Melanoma Patient with Hemophagocytic Lymphohistiocytosis after Nivolumab and Ipilimumab Combined Immunotherapy.
Pacholczak-Madej R; Grela-Wojewoda A; Lompart J; Żuchowska-Vogelgesang B; Ziobro M
Prague Med Rep; 2022; 123(1):35-42. PubMed ID: 35248163
[TBL] [Abstract][Full Text] [Related]
7. Neurologic Serious Adverse Events Associated with Nivolumab Plus Ipilimumab or Nivolumab Alone in Advanced Melanoma, Including a Case Series of Encephalitis.
Larkin J; Chmielowski B; Lao CD; Hodi FS; Sharfman W; Weber J; Suijkerbuijk KPM; Azevedo S; Li H; Reshef D; Avila A; Reardon DA
Oncologist; 2017 Jun; 22(6):709-718. PubMed ID: 28495807
[TBL] [Abstract][Full Text] [Related]
8. Immune checkpoint inhibitor-associated hemophagocytic lymphohistiocytosis in a patient with chronic lymphocytic leukemia.
Ali SB; Kuss B; Karapetis C; Hughes T; Smith A
Immunotherapy; 2023 Dec; 15(18):1531-1537. PubMed ID: 37933523
[TBL] [Abstract][Full Text] [Related]
9. Hemophagocytic lymphohistiocytosis induced by nivolumab/ipilimumab combination therapy: A case of lung adenocarcinoma that responded to early steroid pulse therapy.
Hagiwara S; Tanizaki J; Hayashi H; Komeda Y; Nishida N; Yoshida A; Yamamoto T; Matsubara T; Kudo M
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1960. PubMed ID: 38196303
[TBL] [Abstract][Full Text] [Related]
10. A Case Report of Hemophagocytic Lymphohistiocytosis and Meningitis Due to Atezolizumab Treatment for Lung Adenocarcinoma.
Ota H; Munechika M; Tobino K; Uchida K; Muarakami Y
Cureus; 2024 Apr; 16(4):e58253. PubMed ID: 38745801
[TBL] [Abstract][Full Text] [Related]
11. Hemophagocytic Lymphohistiocytosis Secondary to PD-1 and IDO Inhibition in a Patient with Refractory Glioblastoma.
Thummalapalli R; Heumann T; Stein J; Khan S; Priemer DS; Duffield AS; Laterra J; Couzi R; Lim M; Holdhoff M
Case Rep Oncol; 2020; 13(2):508-514. PubMed ID: 32518546
[TBL] [Abstract][Full Text] [Related]
12. Haemophagocytic lymphohistiocytosis in patients treated with immune checkpoint inhibitors: analysis of WHO global database of individual case safety reports.
Noseda R; Bertoli R; Müller L; Ceschi A
J Immunother Cancer; 2019 May; 7(1):117. PubMed ID: 31046841
[TBL] [Abstract][Full Text] [Related]
13. Reactive Hemophagocytic Lymphohistiocytosis Secondary to Ovarian Adenocarcinoma: A Rare Case Report.
Li XY; Zhu SM; Li XY; Dong RS; Zhang AA; Li SJ; Geng YL
J Inflamm Res; 2022; 15():5121-5128. PubMed ID: 36097636
[TBL] [Abstract][Full Text] [Related]
14. Pembrolizumab-induced Hemophagocytic Lymphohistiocytosis: an immunotherapeutic challenge.
Kalmuk J; Puchalla J; Feng G; Giri A; Kaczmar J
Cancers Head Neck; 2020; 5():3. PubMed ID: 32025343
[TBL] [Abstract][Full Text] [Related]
15. Hemophagocytic Lymphohistiocytosis Associated with Immunological Checkpoint Inhibitors: A Pharmacovigilance Study.
Diaz L; Jauzelon B; Dillies AC; Le Souder C; Faillie JL; Maria ATJ; Palassin P
J Clin Med; 2023 Mar; 12(5):. PubMed ID: 36902771
[TBL] [Abstract][Full Text] [Related]
16. Extreme hyperferritinemia in the setting of acute myeloid leukaemia: a case report of hemophagocytic lymphohistiocytosis.
Denimal D; Ménégaut L; Rossi C; Duvillard L; Masson D
Biochem Med (Zagreb); 2016; 26(2):255-9. PubMed ID: 27346972
[TBL] [Abstract][Full Text] [Related]
17. Hemophagocytic Lymphohistiocytosis in Renal Transplant Recipients: A 2-Case Report.
Mascia G; Argiolas D; Carta E; Ibba S; Piredda GB
Transplant Proc; 2020 Jun; 52(5):1566-1569. PubMed ID: 32389490
[TBL] [Abstract][Full Text] [Related]
18. Secondary hemophagocytic lymphohistiocytosis due to nivolumab/ipilimumab in a renal cell cancer patient-A case report.
Masood A; Wahab A; Clifford T; Weaver EJ; Ehsan H; El Ayass W
Clin Case Rep; 2021 Dec; 9(12):e05184. PubMed ID: 34917381
[TBL] [Abstract][Full Text] [Related]
19. A case of pembrolizumab-induced hemophagocytic lymphohistiocytosis successfully treated with pulse glucocorticoid therapy.
Takahashi H; Koiwa T; Fujita A; Suzuki T; Tagashira A; Iwasaki Y
Respir Med Case Rep; 2020; 30():101097. PubMed ID: 32489850
[TBL] [Abstract][Full Text] [Related]
20. Haemophagocytic Lymphohistiocytosis Following the anti-PD-1 Nivolumab in a Patient with Gastric Cancer and Ankylosing Spondylitis.
Long C; Al-Abdulmalek A; Lai J; Haegert DG; Isnard S; Cournoyer D; Routy JP
Eur J Case Rep Intern Med; 2024; 11(5):004370. PubMed ID: 38715877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
